• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型血管扩张剂匹那地尔(P 1134)对兔血管组织中钾、去甲肾上腺素和5-羟色胺诱导收缩的影响。

Effect of a new vasodilator, pinacidil (P 1134), on potassium, noradrenaline and serotonin induced contractions in rabbit vascular tissues.

作者信息

Nielsen C K, Arrigoni-Martelli E

出版信息

Acta Pharmacol Toxicol (Copenh). 1981 Nov;49(5):427-31. doi: 10.1111/j.1600-0773.1981.tb00927.x.

DOI:10.1111/j.1600-0773.1981.tb00927.x
PMID:7345884
Abstract

Ring preparations of rabbit aorta were contracted by potassium (127 mM). Pinacidil (P 1134), a new vasodilator ( 2.3 x 10(-5) M), the calcium antagonists verapamil (3.4 x 10(-7) M), nifedipine (3.4 x 10(-9) M) and hydralazine (1.9 x 10(-4) M) relaxed the preparation by 50%. 50% relaxation of noradrenaline-contracted tissues was obtained with pinacidil, 6.8 x 10(-5) M, verapamil, 2.4 x 10(-3) M. At 2 x 10(-7) M concentration nifedipine was almost inactive. In ring preparations of rabbit aorta exposed to calcium-free medium and then depolarized with potassium (127 mM), pinacidil, 5 x 10(-5) M and nifedipine, 10(-8) M significantly inhibited the contractions by cumulative addition of calcium. Hydralazine, 10(-3) M had no effect. Noradrenaline-induced contractions in calcium-free medium or in presence of increasing amounts of calcium were significantly inhibited by nifedipine, 10(-8) M and hydralazine, 10(-3) M. Pinacidil, 10(-4) M had no effect. Pinacidil, 1.3 x 10(-5) M and verapamil, 2.0 x 10(-5) M inhibited by 50% the serotonin-induced increase of perfusion pressure of isolated rabbit ear artery. The noradrenaline effect in this preparation were 50% inhibited by pinacidil, 2.4 x 10(-4) M and by verapamil, 8.8 x 10(-5) M. Hydralazine, 10(-3) M exerted minor inhibitory effect. It is suggested that interference with calcium influx contributes to the vasodilator activity of pinacidil.

摘要

兔主动脉环标本在加入127 mM钾后收缩。新型血管扩张剂匹那地尔(P 1134,2.3×10⁻⁵ M)、钙拮抗剂维拉帕米(3.4×10⁻⁷ M)、硝苯地平(3.4×10⁻⁹ M)和肼屈嗪(1.9×10⁻⁴ M)可使标本松弛50%。匹那地尔(6.8×10⁻⁵ M)、维拉帕米(2.4×10⁻³ M)可使去甲肾上腺素收缩的组织松弛50%。在2×10⁻⁷ M浓度时,硝苯地平几乎无活性。在暴露于无钙培养基后再用钾(127 mM)去极化的兔主动脉环标本中,5×10⁻⁵ M的匹那地尔和10⁻⁸ M的硝苯地平通过累积添加钙可显著抑制收缩。10⁻³ M的肼屈嗪无作用。在无钙培养基中或存在逐渐增加量钙的情况下,10⁻⁸ M的硝苯地平和10⁻³ M的肼屈嗪可显著抑制去甲肾上腺素诱导的收缩。10⁻⁴ M的匹那地尔无作用。1.3×10⁻⁵ M的匹那地尔和2.0×10⁻⁵ M的维拉帕米可使50%的5-羟色胺诱导的离体兔耳动脉灌注压升高受到抑制。在该标本中,2.4×10⁻⁴ M的匹那地尔和8.8×10⁻⁵ M的维拉帕米可使去甲肾上腺素的作用受到50%的抑制。10⁻³ M的肼屈嗪产生轻微抑制作用。提示对钙内流的干扰有助于匹那地尔的血管扩张活性。

相似文献

1
Effect of a new vasodilator, pinacidil (P 1134), on potassium, noradrenaline and serotonin induced contractions in rabbit vascular tissues.新型血管扩张剂匹那地尔(P 1134)对兔血管组织中钾、去甲肾上腺素和5-羟色胺诱导收缩的影响。
Acta Pharmacol Toxicol (Copenh). 1981 Nov;49(5):427-31. doi: 10.1111/j.1600-0773.1981.tb00927.x.
2
Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.在猪冠状动脉和豚鼠结肠带中研究吡那地尔、尼可地尔、肼屈嗪和硝苯地平的舒张作用。
Arch Int Pharmacodyn Ther. 1986 Sep;283(1):124-33.
3
Vasodilatation induced by pinacidil in dogs. Comparison with hydralazine and nifedipine.匹那地尔在犬体内诱导的血管舒张作用。与肼屈嗪和硝苯地平的比较。
J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1118-26. doi: 10.1097/00005344-198511000-00017.
4
Effect of cromakalim on contractions in rabbit isolated renal artery in the presence and absence of extracellular Ca2+.在有和没有细胞外钙离子存在的情况下,克罗卡林对兔离体肾动脉收缩的影响。
Br J Pharmacol. 1989 Dec;98(4):1303-11. doi: 10.1111/j.1476-5381.1989.tb12678.x.
5
Comparison of the effects of a new vasodilator pinacidil and nifedipine on isolated blood vessels.新型血管扩张剂匹那地尔与硝苯地平对离体血管作用的比较。
Acta Pharmacol Toxicol (Copenh). 1982 Nov;51(5):407-12. doi: 10.1111/j.1600-0773.1982.tb01045.x.
6
Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.尼群地平(BAY e 5009)、硝苯地平、维拉帕米、酚妥拉明、罂粟碱和米诺地尔对离体兔主动脉平滑肌收缩的影响。
J Cardiovasc Pharmacol. 1982 Nov-Dec;4(6):895-902.
7
Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine.
J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1195-200. doi: 10.1097/00005344-198611000-00015.
8
Characteristics of KRN2391, a novel vasodilator, compared with those of cromakalim, pinacidil and nifedipine in rat aorta.新型血管扩张剂KRN2391与克罗卡林、匹那地尔和硝苯地平在大鼠主动脉中的特性比较。
Eur J Pharmacol. 1991 Apr 10;196(1):1-7. doi: 10.1016/0014-2999(91)90401-b.
9
Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.维拉帕米、地尔硫䓬和硝苯地平可阻断去极化诱导的家兔主动脉和猪冠状动脉中去甲肾上腺素收缩作用的增强。
J Pharmacol Exp Ther. 1986 Dec;239(3):808-13.
10
Comparison of in vitro effects of cicletanine, its enantiomers and major metabolite on rat thoracic aorta.西氯他宁及其对映体和主要代谢产物对大鼠胸主动脉的体外作用比较。
Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):548-52. doi: 10.1007/BF00166749.

引用本文的文献

1
Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.匹那地尔对正常血压志愿者血流动力学效应的药效学模型
Eur J Clin Pharmacol. 1993;44(2):177-82. doi: 10.1007/BF00315477.
2
Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
Eur J Clin Pharmacol. 1984;26(5):603-8. doi: 10.1007/BF00543493.
3
Acute haemodynamic effects of pinacidil in man.匹那地尔对人体的急性血流动力学效应。
Br J Clin Pharmacol. 1986 Sep;22(3):287-92. doi: 10.1111/j.1365-2125.1986.tb02889.x.
4
Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea-pig smooth muscle differs from that of glyceryl trinitrate.吡那地尔对大鼠和豚鼠平滑肌的抑制作用机制与硝酸甘油不同的证据。
Br J Pharmacol. 1987 Jun;91(2):421-9. doi: 10.1111/j.1476-5381.1987.tb10297.x.
5
Pinacidil. Preclinical investigations.
Drugs. 1988;36 Suppl 7:4-9. doi: 10.2165/00003495-198800367-00003.
6
In vitro studies on the mode of action of pinacidil.关于匹那地尔作用方式的体外研究。
Drugs. 1988;36 Suppl 7:10-28. doi: 10.2165/00003495-198800367-00004.
7
The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques.吡那地尔的钾通道开放作用;运用生化、离子通量及微电极技术的研究
Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):310-8. doi: 10.1007/BF00173406.
8
Smooth muscle K+ channel openers; their pharmacology and clinical potential.平滑肌钾通道开放剂;其药理学及临床应用潜力
Pflugers Arch. 1989;414 Suppl 1:S99-105. doi: 10.1007/BF00582256.
9
Effects of putative activators of K+ channels in mouse pancreatic beta-cells.钾通道假定激活剂对小鼠胰腺β细胞的影响。
Br J Pharmacol. 1989 Nov;98(3):957-65. doi: 10.1111/j.1476-5381.1989.tb14626.x.
10
Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
Drugs. 1990 Jun;39(6):929-67. doi: 10.2165/00003495-199039060-00008.